Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

New compounds may soon be tested to treat excessive hair growth in women.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.